Finotonlimab A China IO Latecomer But First In Country For 1L HNSCC

 
• By Dexter Jie Yan
  
Sinocelltech has added a seventeenth PD-1/L1 drug to the Chinese market. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from R&D